Literature DB >> 1601898

Glow discharge plasma deposition of tetraethylene glycol dimethyl ether for fouling-resistant biomaterial surfaces.

G P López1, B D Ratner, C D Tidwell, C L Haycox, R J Rapoza, T A Horbett.   

Abstract

The glow discharge plasma deposition (GDPD) of tetraethylene glycol dimethyl ether is introduced as a novel method for obtaining surfaces that are resistant to protein adsorption and cellular attachment. Analysis of films by x-ray photoelectron spectroscopy and several biological assays indicate the formation of a fouling-resistant, PEO-like surface on several substrata (e.g., glass, polytetrafluoroethylene, polyethylene). Adsorption of 125I-radiolabelled proteins (fibrinogen, albumin and IgG) from buffer and plasma was very low (typically less than 20 ng/cm2) when compared to the untreated substrata, which exhibited much higher levels of protein adsorption. Not all coated substrata adsorbed equal amounts of protein (e.g., coated glass samples typically adsorbed more protein than coated polyethylene or coated polytetrafluoroethylene samples), suggesting that the substratum used may affect the amount of protein adsorbed. Measurement of dynamic platelet adhesion, using epifluorescent video microscopy, and endothelial cell attachment further demonstrates the short-term nonadhesiveness of these surfaces.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1601898     DOI: 10.1002/jbm.820260402

Source DB:  PubMed          Journal:  J Biomed Mater Res        ISSN: 0021-9304


  26 in total

1.  An X-ray and neutron reflectometry study of 'PEG-like' plasma polymer films.

Authors:  Donna J Menzies; Andrew Nelson; Hsin-Hui Shen; Keith M McLean; John S Forsythe; Thomas Gengenbach; Celesta Fong; Benjamin W Muir
Journal:  J R Soc Interface       Date:  2011-09-28       Impact factor: 4.118

Review 2.  Biocompatible and bioactive surface modifications for prolonged in vivo efficacy.

Authors:  Steven R Meyers; Mark W Grinstaff
Journal:  Chem Rev       Date:  2011-10-18       Impact factor: 60.622

3.  Formation of osteogenic colonies on well-defined adhesion peptides by freshly isolated human marrow cells.

Authors:  Ada Au; Cynthia A Boehm; Anne M Mayes; George F Muschler; Linda G Griffith
Journal:  Biomaterials       Date:  2007-01-11       Impact factor: 12.479

4.  Centrifugal deposition of microgels for the rapid assembly of nonfouling thin films.

Authors:  Antoinette B South; Rachel E Whitmire; Andrés J García; L Andrew Lyon
Journal:  ACS Appl Mater Interfaces       Date:  2009-12       Impact factor: 9.229

Review 5.  Significance of bacterial surface-active compounds in interaction of bacteria with interfaces.

Authors:  T R Neu
Journal:  Microbiol Rev       Date:  1996-03

6.  Free radical functionalization of surfaces to prevent adverse responses to biomedical devices.

Authors:  Marcela M M Bilek; Daniel V Bax; Alexey Kondyurin; Yongbai Yin; Neil J Nosworthy; Keith Fisher; Anna Waterhouse; Anthony S Weiss; Cristobal G dos Remedios; David R McKenzie
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-15       Impact factor: 11.205

7.  Modulation of fibroblast inflammatory response by surface modification of a perfluorinated ionomer.

Authors:  Thelma I Valdes; Winston Ciridon; Buddy D Ratner; James D Bryers
Journal:  Biointerphases       Date:  2011-06       Impact factor: 2.456

Review 8.  Biomimetic strategies based on viruses and bacteria for the development of immune evasive biomaterials.

Authors:  Matthew T Novak; James D Bryers; William M Reichert
Journal:  Biomaterials       Date:  2009-01-29       Impact factor: 12.479

9.  Surface modification of a perfluorinated ionomer using a glow discharge deposition method to control protein adsorption.

Authors:  Thelma I Valdes; Winston Ciridon; Buddy D Ratner; James D Bryers
Journal:  Biomaterials       Date:  2007-12-21       Impact factor: 12.479

Review 10.  Superhydrophobic materials for biomedical applications.

Authors:  Eric J Falde; Stefan T Yohe; Yolonda L Colson; Mark W Grinstaff
Journal:  Biomaterials       Date:  2016-07-09       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.